Filing Details
- Accession Number:
- 0001209191-18-048986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-30 17:26:19
- Reporting Period:
- 2018-08-28
- Accepted Time:
- 2018-08-30 17:26:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201256 | S Michael Wyzga | C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-08-28 | 2,468 | $74.85 | 9,112 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Column 4 were effected to cover anticipated tax liabilities arising out of stock compensation. The reporting person adopted a Rule 10b5-1 Trading Plan pursuant to which these sales would have occurred on or about July 27, 2018 but due to administrative error the sales did not occur as initially planned.